Exeter Kidney Unit (Renal)
Browse by
Research outputs from the Exeter Kidney Unit (Renal services) at the RD&E.
Recent Submissions
-
Remission of membranous nephropathy after treatment of localised prostate cancer
(Karger, 2019-06)Membranous nephropathy is a cause of the nephrotic syndrome in adults; it can be a primary or secondary process. Secondary causes include solid organ and lymphoid malignancies. Prostate cancer has been reported as the ... -
New insights on the genetics of type 1 diabetes
(Wolters Kluwer, 2019-08)The genetic risk for type 1 diabetes has been studied for over half a century, with the strong genetic associations of type 1 diabetes forming critical evidence for the role of the immune system in pathogenesis. In this ... -
Reducing our carbon footprint and resource use on the Exeter Kidney Unit
(2019-07)Conference poster presented at the James Lovelock Centenary conference 'The Future of Global Systems Thinking', University of Exeter, 29th-31st July 2019. -
Renal nurses' lived experiences of discussions about sexuality
(Mark Allen Group, 2019-03)Renal teams focus predominantly on renal replacement therapy and physical symptom management, rather than psychological issues, such as mental health, body image or self-esteem. This study aims to increase understanding ... -
Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes
(Springer, 2019-07)Late-onset type 1 diabetes can be difficult to identify. Measurement of endogenous insulin secretion using C-peptide provides a gold standard classification of diabetes type in longstanding diabetes that closely relates ... -
Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?
(Wiley, 2019-04)Most people with Type 1 diabetes have low levels of persistent endogenous insulin production. The Diabetes Control and Complications Trial showed that close to diagnosis preserved endogenous insulin was associated with ... -
Up to date on phosphate management and phosphate binders
(Mark Allen Group, 2019-02)Although the cause of hyperphosphatemia remains the same, its management through dietary advice and medication is changing to keep up with the latest evidence. This article discusses some of the recent updates to the KDIGO ... -
Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis.
(American Diabetes Association, 2019-02)Previously generated genetic risk scores (GRSs) for type 1 diabetes (T1D) have not captured all known information at non-HLA loci or, particularly, at HLA risk loci. We aimed to more completely incorporate HLA alleles, ... -
A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO).
(BioMed Central, 2019-01-10)Iron deficiency is frequent in haemodialysis (HD) patients with chronic kidney disease (CKD), and intravenous iron is an established therapy for these patients. This study assessed treatment routine, effectiveness, and ... -
Young adults' perspectives on living with kidney failure: a systematic review and thematic synthesis of qualitative studies.
(BMJ, 2018-01)Young adults fare worse than younger adolescents or older adults on a broad range of health indicators. Those with a chronic illness such as renal failure are a particularly vulnerable group, who experience poor outcomes ... -
Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletion.
(BioMed Central, 2018-07-18)Heterozygous mutation of the transcription factor HNF1B is the most common cause of monogenetic developmental renal disease. Disease-associated mutations fall into two categories: HNF1B intragenic mutations and a 1.3 Mb ... -
Prescribing analgesia for patients with impaired renal function.
(Mark Allen Group, 2018-05-02) -
Clinical and research uses of genetic risk scores in type 1 diabetes.
(Elsevier, 2018-04-24)Type 1 diabetes (T1D) is a chronic disease of high blood glucose caused by autoimmune destruction of pancreatic beta cells eventually resulting in severe insulin deficiency. T1D has a significant heritable risk. Genetic ... -
Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β–associated renal disease and can be symptomatic
(Oxford Journals, 2018-01-30) -
Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation.
(Oxford Academic, 2017-07-01)Immunosuppression is required in kidney transplantation to prevent rejection and prolong graft survival. We conducted an economic evaluation to support England's National Institute for Health and Care Excellence in developing ... -
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab.
(American Academy of Pediatrics, 2017-09)We describe a case of invasive meningococcal disease due to a vaccine-preventable and penicillin-resistant strain in a fully immunized young adult on long-term complement inhibitor therapy and daily penicillin chemoprophylaxis. ... -
Discovery of a novel dominant mutation in the REN gene after forty years of renal disease: a case report.
(BioMed Central, 2017-07-12)Heterozygous mutations in the gene encoding renin (REN) cause autosomal dominant tubulointerstitial kidney disease (ADTKD), early-onset anaemia and hyperuricaemia; only four different mutations have been described in the ... -
Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
(NIHR, 2016-08)End-stage renal disease is a long-term irreversible decline in kidney function requiring renal replacement therapy: kidney transplantation, haemodialysis or peritoneal dialysis. The preferred option is kidney transplantation, ...
RSS 1.0